Literature DB >> 31179067

The use of surgery in a real-world clinic to diagnose and treat pulmonary cryptococcosis in immunocompetent patients.

Bumhee Yang1, Hyun Lee2, Taebum Lee3, Sun-Hyung Kim4, Min Young Kim5, Byeong-Ho Jeong4, Sumin Shin6, Seonwoo Kim7, Kyung Soo Lee5, O Jung Kwon4, Hojoong Kim4.   

Abstract

BACKGROUND: We evaluated the role played by surgery in the diagnosis and treatment of pulmonary cryptococcosis (PC) in immunocompetent subjects.
METHODS: We retrospectively studied 53 immunocompetent patients who were pathologically diagnosed with PC between January 2000 and December 2016 in a tertiary referral center. We compared the radiological presentations of, and diagnostic modalities used to evaluate, patients diagnosed both surgically and non-surgically. We also compared the treatment outcomes of patients who underwent surgical resection alone and those who received additional antifungals following surgical resection.
RESULTS: Of the 53 patients, 30 (57%) were diagnosed via non-surgical modalities including percutaneous needle biopsy (PCNB) (n=29) and transbronchial lung biopsy (TBLB) (n=1); and 23 (43%) were diagnosed by surgical modalities including video-assisted thoracoscopic wedge resection (n=22) and lobectomy (n=1). An initial clinical suspicion of a lung malignancy was associated with the use of surgical diagnostic approaches (P<0.001). Whereas undetermined locations were associated with the use of surgical diagnostic approaches, radiological findings such as clustered nodular patterns (P<0.001), cavities (P=0.005), air bronchograms (P<0.001), and peripheral lesions (P<0.001) were associated with the use of non-surgical diagnostic approaches. Of the 30 non-surgically diagnosed patients, 21 (70%) were treated with antifungals and 9 (30%) were followed-up without treatment. Of the 23 patients who underwent surgical treatment, 8 received additional antifungals. The proportion of patients who had radiological improvement was significantly higher in surgically diagnosed patients than non-surgically diagnosed patients (100% vs. 73%; P=0.007). However, there was no significant difference in disease progression between patients who underwent surgical resection alone and those who additionally received antifungals (P=0.999).
CONCLUSIONS: Surgical resection was required in some patients to diagnose PC. An initial suspicion of a lung malignancy was associated with use of surgical diagnostic approaches. Surgical resection not only afforded reliable diagnoses but also effectively treated PC. There was no need for additional antifungals after complete surgical resection.

Entities:  

Keywords:  Pulmonary cryptococcosis (PC); antifungal; diagnosis; surgery; treatment

Year:  2019        PMID: 31179067      PMCID: PMC6531691          DOI: 10.21037/jtd.2019.04.17

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  22 in total

1.  Treatment of asymptomatic pulmonary cryptococcosis in immunocompetent hosts with oral fluconazole.

Authors:  Kyoung Hwa Choi; Seoung Ju Park; Kyung Hoon Min; So Ri Kim; Min Hee Lee; Chi Ryang Chung; Hyo Jin Han; Yong Chul Lee
Journal:  Scand J Infect Dis       Date:  2011-01-28

2.  Computed tomography (CT) and positron emission tomography with [18F]fluoro-2-deoxy-D-glucose (FDG-PET) images of pulmonary cryptococcosis mimicking lung cancer.

Authors:  Hitoshi Igai; Masashi Gotoh; Hiroyasu Yokomise
Journal:  Eur J Cardiothorac Surg       Date:  2006-10-23       Impact factor: 4.191

3.  Pulmonary cryptococcosis in patients without HIV infection.

Authors:  J A Aberg; L M Mundy; W G Powderly
Journal:  Chest       Date:  1999-03       Impact factor: 9.410

4.  Epidemiology and host- and variety-dependent characteristics of infection due to Cryptococcus neoformans in Australia and New Zealand. Australasian Cryptococcal Study Group.

Authors:  S Chen; T Sorrell; G Nimmo; B Speed; B Currie; D Ellis; D Marriott; T Pfeiffer; D Parr; K Byth
Journal:  Clin Infect Dis       Date:  2000-09-07       Impact factor: 9.079

5.  Pulmonary cryptococcosis in immunocompetent patients: CT findings in 12 patients.

Authors:  Danial L Fox; Nestor L Müller
Journal:  AJR Am J Roentgenol       Date:  2005-09       Impact factor: 3.959

6.  Pulmonary cryptococcosis: CT findings in immunocompetent patients.

Authors:  Rebecca M Lindell; Thomas E Hartman; Hassan F Nadrous; Jay H Ryu
Journal:  Radiology       Date:  2005-07       Impact factor: 11.105

7.  Pulmonary cryptococcosis: imaging findings in 23 non-AIDS patients.

Authors:  Kyoung Doo Song; Kyung Soo Lee; Man Pyo Chung; O Jung Kwon; Tae Sung Kim; Chin A Yi; Myung Jin Chung
Journal:  Korean J Radiol       Date:  2010-06-21       Impact factor: 3.500

8.  Pulmonary cryptococcosis in solid organ transplant recipients: clinical relevance of serum cryptococcal antigen.

Authors:  Nina Singh; Barbara D Alexander; Olivier Lortholary; Françoise Dromer; Krishan L Gupta; George T John; Ramon del Busto; Goran B Klintmalm; Jyoti Somani; G Marshall Lyon; Kenneth Pursell; Valentina Stosor; Patricia Muñoz; Ajit P Limaye; Andre C Kalil; Timothy L Pruett; Julia Garcia-Diaz; Atul Humar; Sally Houston; Andrew A House; Dannah Wray; Susan Orloff; Lorraine A Dowdy; Robert A Fisher; Joseph Heitman; Marilyn M Wagener; Shahid Husain
Journal:  Clin Infect Dis       Date:  2008-01-15       Impact factor: 9.079

9.  Pulmonary cryptococcosis: comparison of clinical and radiographic characteristics in immunocompetent and immunocompromised patients.

Authors:  Wei-Chou Chang; Ching Tzao; Hsian-He Hsu; Shih-Chun Lee; Kun-Lun Huang; Ho-Jui Tung; Cheng-Yu Chen
Journal:  Chest       Date:  2006-02       Impact factor: 9.410

10.  Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of america.

Authors:  John R Perfect; William E Dismukes; Francoise Dromer; David L Goldman; John R Graybill; Richard J Hamill; Thomas S Harrison; Robert A Larsen; Olivier Lortholary; Minh-Hong Nguyen; Peter G Pappas; William G Powderly; Nina Singh; Jack D Sobel; Tania C Sorrell
Journal:  Clin Infect Dis       Date:  2010-02-01       Impact factor: 9.079

View more
  3 in total

1.  Follow-Up of Surgical or Nonsurgical Patients with Pulmonary Cryptococcosis: A Real-World Study.

Authors:  Herui Li; Yiming Ma; Zihang Zeng; Lijuan Luo; Tiao Li; Huihui Zeng; Yan Chen
Journal:  Infect Drug Resist       Date:  2022-07-11       Impact factor: 4.177

2.  Clinical characteristics and image features of pulmonary cryptococcosis: a retrospective analysis of 50 cases in a Chinese hospital.

Authors:  Yuan Lu; Ming Ding; Jing Huang; Cuiping Fu; Yi Wan; Jun Jiang; Jie Huang
Journal:  BMC Pulm Med       Date:  2022-04-08       Impact factor: 3.317

3.  The clinical and radiological characteristics of pulmonary cryptococcosis in immunocompetent and immunocompromised patients.

Authors:  Yan Hu; Si-Ying Ren; Peng Xiao; Feng-Lei Yu; Wen-Liang Liu
Journal:  BMC Pulm Med       Date:  2021-08-13       Impact factor: 3.317

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.